desipramine has been researched along with Remission, Spontaneous in 2 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Faraone, SV | 1 |
Biederman, J | 1 |
Spencer, T | 1 |
Wilens, T | 1 |
Seidman, LJ | 1 |
Mick, E | 1 |
Doyle, AE | 1 |
Berner, P | 1 |
Kryspin-Exner, K | 1 |
Poeldinger, W | 1 |
1 review available for desipramine and Remission, Spontaneous
Article | Year |
---|---|
Attention-deficit/hyperactivity disorder in adults: an overview.
Topics: Adult; Age Factors; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; | 2000 |
1 trial available for desipramine and Remission, Spontaneous
Article | Year |
---|---|
Therapy possibilities for therapy-resistant depressions.
Topics: Amitriptyline; Antidepressive Agents; Chronic Disease; Clinical Trials as Topic; Depression; Desipra | 1974 |